Motor subtype changes in early Parkinson's disease

https://doi.org/10.1016/j.parkreldis.2017.07.018Get rights and content

Highlights

  • There exist multiple distinct motor subtypes of Parkinson's disease.

  • The majority of Parkinson's disease patients have a tremor-dominant phenotype.

  • Parkinson's disease subtypes vary with disease duration.

Abstract

Introduction

Distinct motor subtypes of Parkinson's disease (PD) have been described through both clinical observation and through data-driven approaches. However, the extent to which motor subtypes change during disease progression remains unknown. Our objective was to determine motor subtypes of PD using an unsupervised clustering methodology and evaluate subtype changes with disease duration.

Methods

The Parkinson's Progression Markers Initiative database of 423 newly diagnosed PD patients was utilized to retrospectively identify unique motor subtypes through a data-driven, hierarchical correlational clustering approach. For each patient, we assigned a subtype to each motor assessment at each follow-up visit (time points) and by using published criteria. We examined changes in PD subtype with disease duration using both qualitative and quantitative methods.

Results

Five distinct motor subtypes were identified based on the motor assessment items and these included: Tremor Dominant (TD), Axial Dominant, Appendicular Dominant, Rigidity Dominant, and Postural and Instability Gait Disorder Dominant. About half of the patients had consistent subtypes at all time points. Most patients met criteria for TD subtype soon after diagnosis. For patients with inconsistent subtypes, there was an overall trend to shift away from a TD phenotype with disease duration, as shown by chi-squared test, p < 0.001, and linear regression analysis, p < 0.05.

Conclusion

These results strongly suggest that classification of motor subtypes in PD can shift with increasing disease duration. Shifting subtypes is a factor that should be accounted for in clinical practice or in clinical trials.

Introduction

It is widely accepted that Parkinson's disease (PD) is a clinically heterogeneous disease with several different motor phenotypes [1], [2]. Accurately characterizing the heterogeneity that occurs in PD is important for assessing prognosis, enrolling in clinical trials, and for screening for possible co-morbidities [3]. Properly subtyping patients is also a critical step for determining inclusion in both preclinical [4], [5] and clinical studies, particularly those involving individualized treatment plans based on motor symptoms [6], [7], [8].

PD subtype categories were originally based on clinical observation of motor symptoms [1], [9]. Commonly recognized subtypes of PD include a tremor dominant (TD) group and a postural instability and gait disorder/difficulty/dominant (PIGD) group [2]. Some clinicians and researchers also recognize an ill-defined intermediate or indeterminate type (IT) classification for patients that do not fit the TD or PIGD phenotype. Recently, studies have proposed additional subtypes based on data-driven cluster analysis approaches using other clinical characteristics including age of onset, speed of disease progression, cognitive measures, and behavioral measures [10], [11], [12], [13], [14]. Aside from establishing subtypes, several studies have attempted to clarify whether subtypes are fixed or whether they represent different stages of disease progression [15], [16].

In this study, our goal was to use a data-driven approach to discover distinct motor subtypes in PD, and to apply these subtypes to longitudinal motor assessment data to look for shift in category over time. To accomplish this task, we used hierarchical correlational clustering on motor assessment data from 423 early PD patients included in the Parkinson's Progression Markers Initiative (PPMI) database (www.ppmi-info.org/data).

Section snippets

Data source

Data used in this study were obtained from the Parkinson's Progression Markers Initiative (PPMI) database (www.ppmi-info.org/data). For up-to-date information on the study, visit www.ppmi-info.org. Further details on the PPMI project have been previously published [17]. The study was approved by the Institutional Review Board (IRB) at all participating institutions. The PPMI database offers unique access to longitudinal data from 423 early PD patients. Participants were required to enroll

Results

The number of total motor score assessments available in the PPMI database varies between 2 and 14 for each patient (M = 6.81, SD = 2.40). Follow-up visits for the sample as a whole occurred between 0 and 7.84 years after diagnosis (M = 1.63, SD = 1.46). The vast majority (96.4%) of time points were within 5 years of diagnosis. A total of 2866 motor score assessments were used for clustering, which resulted in three overall clusters: TD, IT, and PIGD. Within IT, three specific clusters emerged:

Discussion

Our results identified an additional AxD, ApD, and RD subtypes of PD, in addition to the previously reported TD, IT, and PIGD subtypes [2]. Our methods employed a novel, unsupervised machine learning approach to isolate different motor subtypes in newly diagnosed PD by using MDS-UPDRS motor assessment data. These results also suggested that early PD sub-classification was stable for some patients, but quite unstable for others. Around 60% of patients are classified as TD and 20% as PIGD within

Author roles

Research Project: Conception – RSE, KDF; Organization – RSE, CWH, DM-R; Execution – RSE.

Statistical Analysis: Design – RSE; Execution – RSE; Review and Critique – RSE, CWH, DM-R, LA, MSO, AG.

Manuscript: Writing of the First Draft – RSE; Review and Critique – RSE, CWH, DM-R, LA, MSO, AG.

Funding sources

This work was supported by the UF Pruitt Family Endowed Faculty Fellowship. PPMI – a public private partnership – is funded by the Michael J. Fox Foundation for Parkinson's Research (9558) and funding partners, including Abbvie, Avid Radiopharmaceuticals, Biogen, Bristol-Myers Squibb, Covance, GE Healthcare, Genentech, GlaxoSmithKline, Lilly, Lindbeck, Merck, Meso Scale Discovery, Pfizer, Piramal, Roche, Sanofi Genzyme, Servier, Teva, UCB, and Golub Capital.

Disclosures

R.S.E has no financial disclosures to report.

C.W.H. receives grant support from the University of Florida Clinical and Translational Research Institute, which is supported in part by NIH award KL2 TR001429. He has served as a research committee member for the Michael J. Fox Foundation and as a speaker for the National Parkinson Foundation, the Parkinson's Disease Foundation, and the Davis Phinney Foundation. Dr. Hess has participated in CME and educational activities on movement disorders

Acknowledgements

The authors thank the Michael J. Fox Foundation for Parkinson's Research for driving the PPMI development efforts, and all investigators that contributed to the database. We also thank Jackson Cagle, Stephanie Cernera, Enrico Opri, and Rene Molina for helpful discussion and feedback.

References (29)

  • J.S.A.M. Reijnders et al.

    The association between motor subtypes and psychopathology in Parkinson's disease

    Park. Relat. Disord.

    (2009)
  • T. Simuni et al.

    How stable are Parkinson's disease subtypes in de novo patients: analysis of the PPMI cohort?

    Park. Relat. Disord.

    (2016)
  • W.J. Zetusky et al.

    The heterogeneity of Parkinson's disease clinical and prognostic implications

    Neurology

    (1985)
  • T. Foltynie et al.

    The heterogeneity of idiopathic Parkinson's disease

    J. Neurol.

    (2002)
  • M. Selikhova et al.

    A clinico-pathological study of subtypes in Parkinson's disease

    Brain

    (2009)
  • J. Clarimón et al.

    Tremor dominant parkinsonism: clinical description and LRRK2 mutation screening

    Mov. Disord.

    (2008)
  • O. Corti et al.

    What genetics tells us about the causes and mechanisms of Parkinson's disease

    Physiol. Rev.

    (2011)
  • N. Giladi et al.

    A personalized approach to Parkinson's disease patients based on founder mutation analysis

    Front. Neurol.

    (2016)
  • J. Marjama-Lyons et al.

    Tremor-predominant Parkinson's disease

    Drugs & Aging

    (2000)
  • M. Katz et al.

    Differential effects of deep brain stimulation target on motor subtypes in Parkinson's disease

    Ann. Neurol.

    (2015)
  • J. Jankovic et al.

    Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. the Parkinson study group

    Neurology

    (1990)
  • B. Post et al.

    Clinical heterogeneity in newly diagnosed Parkinson's disease

    J. Neurol.

    (2008)
  • S.J.G. Lewis et al.

    Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach

    J. Neurology, Neurosurg. Psychiatry

    (2005)
  • J.M. Graham et al.

    A data-driven approach to the study of heterogeneity in idiopathic Parkinson's disease: identification of three distinct subtypes

    Mov. Disord.

    (1999)
  • Cited by (32)

    • Enhanced neuroimaging genetics using multi-view non-negative matrix factorization with sparsity and prior knowledge

      2022, Medical Image Analysis
      Citation Excerpt :

      Similar to other neurodegenerative diseases, PD also exhibits heterogeneous development and progression of various motor and non-motor symptoms (i.e., axial symptoms, cognitive impairment, speed of disease progression, etc.) (Rodríguez-Violante et al., 2017). To probe this heterogeneity in PD, many studies have attempted to divide PD into subgroups based on motor or non-motor symptoms, but currently, there is no consensus on how to do this (Eisinger et al., 2017; Mu et al., 2017; Sauerbier et al., 2016). Therefore, it is crucial to identify the complex mechanisms underlying PD.

    • Parkinson's disease motor subtype changes during 20 years of follow-up

      2020, Parkinsonism and Related Disorders
      Citation Excerpt :

      Large datasets with long-term follow-up are needed to ensure representative data that span the full spectrum of PD symptom heterogeneity. Despite vast differences in subtyping categories seen throughout the literature [16–19], an emerging consensus is the subtype designations for tremor dominant (TD) patients and postural instability and gait disorder/dominance (PIGD) as defined by motor assessment [8,16]. In this schema, individuals not fitting criteria for TD or PIGD are placed into an intermediate/indeterminate type (IT) category.

    • The late stage of Parkinson's –results of a large multinational study on motor and non-motor complications

      2020, Parkinsonism and Related Disorders
      Citation Excerpt :

      Alternatively, some patients may not have received high enough doses of dopaminergic medications to develop dyskinesia, in agreement with previous findings in a study of Dutch nursing homes where many patients appeared to be relatively undertreated (3). Similarly, only 11% had moderate to severe tremor despite high overall motor scores, in keeping with the observations that many patients with the tremor subtype lose their tremor and develop the akinetic rigid subtype with longer follow-up [26,27]. It is also noteworthy that a proportion of 16.5% of patients had moderate to severe impulse control disorders, even in the advanced stages of the disease, indicating that these should be proactively screened for in this population, and not just in the higher risk group of younger men [28].

    View all citing articles on Scopus
    View full text